Virtu Financial LLC Cabaletta Bio, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $303,471 - $478,018	25,631 New	25,631 $390,000
Q3 2022 Nov 07, 2022	BUY	$0.63 - $2.05 $8,864 - $28,843	14,070 New	14,070 $9,000
Q2 2022 Aug 09, 2022	SELL	$0.99 - $2.11 $12,350 - $26,322	-12,475 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$1.68 - $3.92 $104,658 - $244,204	-62,297 Reduced 83.32%	12,475 $25,000
Q4 2021 Feb 17, 2022	BUY	$3.36 - $14.64 $251,233 - $1.09 Million	74,772 New	74,772 $283,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.